Analysis of NTRK expression in gastric and esophageal adenocarcinoma (AGE) with pan-TRK immunohistochemistry-Reference-Cited by-同舟云学术

Analysis of NTRK expression in gastric and esophageal adenocarcinoma (AGE) with pan-TRK immunohistochemistry

Published:2019-11 Issue:11 Volume:215 Page:152662
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Arnold A.,Daum S.,von Winterfeld M.,Berg E.,Hummel M.,Horst D.,Rau B.,Stein U.,Treese C.

Funder

Charité – University Medicine Berlin and the Berlin Institute of Health

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference17 articles.

1. Screening for NTRK-rearranged tumors using immunohistochemistry: comparison of 2 different pan-TRK clones in melanoma samples;Bourhis;Appl. Immunohistochem. Mol. Morphol.,2019

2. Economic analysis of alternative strategies for detection of ALK rearrangements in non small cell lung cancer;Doshi;Diagnostics (Basel),2016

3. Efficacy of Larotrectinib in TRK fusion-positive cancers in adults and children;Drilon;N. Engl. J. Med.,2018

4. Molecular characterization of cancers with NTRK gene fusions;Gatalica;Mod. Pathol.,2019

5. Pan-trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions;Hechtman;Am. J. Surg. Pathol.,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular NAD+ response to post-hepatectomy liver failure: bridging preclinical and clinical findings;Communications Biology;2024-08-14

2. What Therapeutic Biomarkers in Gastro-Esophageal Junction and Gastric Cancer Should a Pathologist Know About?;Surgical Pathology Clinics;2023-12

3. NTRK gene alterations were enriched in hepatoid or enteroblastic differentiation type of gastric cancer;Journal of Clinical Pathology;2023-07-14

4. The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer;International Journal of Molecular Sciences;2023-05-16

5. Impact of tissue-agnostic approvals for patients with gastrointestinal malignancies;Trends in Cancer;2023-03